Immuno 2026 Day 7 Highlights: Global Access to Immunotherapy and Education
ASTRO 2026 Highlights: The Science and People Behind the Progress
Evis Sala: Deeply Honoured to Have Been Elected President of The ESUR
ESMO 2026 Lung Cancer: 10 Abstracts to Watch
ESMO 2026: What’s Next for Immunotherapy in Thoracic Oncology?
ASCO and WHO Sign Agreement to Expand Access to Quality Cancer Care Worldwide
Ilyas Sahin։ Tile-Based Radiation Therapy vs Stereotactic Radiation After Brain Metastasis Surgery
How Radiation Therapy Kills Cancer Cells: When Does It Start Working?
OncoDaily GI is the dedicated GI cancer platform of OncoDaily, focused on the rapidly evolving field of gastrointestinal oncology. It covers the full spectrum of GI malignancies, including colorectal, anal canal, gastric, gastroesophageal junction (GEJ), esophageal, small bowel, pancreatic, hepatocellular, and biliary tract cancers. Through OncoDaily GI, readers can follow the latest clinical trial developments, ongoing research, FDA and EMA approvals, guideline updates, emerging therapies, advances in biomarkers and precision oncology, major conference findings, and interviews with leading experts in the field.
